← All Thc Therapeutics, INC filings

Thc Therapeutics, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
THCT
Thc Therapeutics, INC
8-K: THC Therapeutics Completes Strategic Acquisition of The Headquarters Group, Expanding Cannabis Footprint and Vertical Integration
THC Therapeutics, Inc. has successfully acquired 100% of The Headquarters Group, Inc. and its subsidiaries in an all-share transaction valued at approximately $11 million, significantly advancing its vertical integration and roll-up strategy in the legal cannabis industry.
OTC.Pink
THCT
Thc Therapeutics, INC
8-K/A: THC Therapeutics Amends 8-K Filing Following Director Removal Dispute
THC Therapeutics files an amendment to its previous 8-K report to include a letter from Brandon Romanek, the former director, contesting his removal from the board.
OTC.Pink
THCT
Thc Therapeutics, INC
8-K: THC Therapeutics Boardroom Shakeup: Brandon Romanek Ousted
THC Therapeutics announces the removal of Brandon Romanek from the Board of Directors and all positions held within the company, effective April 2, 2025.
OTC.Pink
THCT
Thc Therapeutics, INC
8-K/A: THC Therapeutics Dismisses Auditor After PCAOB Revokes Registration
THC Therapeutics has dismissed its auditor, Gries & Associates, after the Public Company Accounting Oversight Board revoked the firm's registration.
OTC.Pink
THCT
Thc Therapeutics, INC
8-K: THC Therapeutics Changes Auditors After SEC Revokes Previous Firm's Registration
THC Therapeutics has dismissed its auditor, Gries & Associates, after the SEC revoked their registration, and has engaged Green Growth CPAs as their new independent accountant.